Oktober 2012
34
Iyer H, Sen M, Prasad C, Rupar CA, and Lindsay RM. 2012. Coma, hyperammonemia, metabolic
acidosis, and mutation: lessons learned in the acute management of late onset urea cycle
disorders. Hemodial Int 16:95-100.
Kido J, Nakamura K, Mitsubuchi H, Ohura T, Takayanagi M, Matsuo M, Yoshino M, Shigematsu Y,
Yorifuji T, Kasahara M, Horikawa R, and Endo F. 2011. Long-term outcome and intervention of urea
cycle disorders in Japan. J Inherit Metab Dis.
Langendonk JG, Roos JC, Angus L, Williams M, Karstens FP, de Klerk JB, Maritz C, Ben-Omran T,
Williamson C, Lachmann RH, and Murphy E. 2012. A series of pregnancies in women with inherited
metabolic disease. J Inherit Metab Dis 35:419-424.
Mendez-Figueroa H, Lamance K, Sutton VR, Aagaard-Tillery K, and Van dV, I. 2010. Management of
ornithine transcarbamylase deficiency in pregnancy. Am J Perinatol 27:775-784.
Mercimek-Mahmutoglu S, Moeslinger D, Haberle J, Engel K, Herle M, Strobl MW, Scheibenreiter S,
Muehl A, and Stockler-Ipsiroglu S. 2010. Long-term outcome of patients with argininosuccinate
lyase deficiency diagnosed by newborn screening in Austria. Mol Genet Metab 100:24-28.
Morgan TM, Schlegel C, Edwards KM, Welch-Burke T, Zhu Y, Sparks R, and Summar M. 2011.
Vaccines are not associated with metabolic events in children with urea cycle disorders. Pediatrics
127:
e1147-e1153.
Morioka D, Kasahara M, Takada Y, Shirouzu Y, Taira K, Sakamoto S, Uryuhara K, Egawa H, Shimada
H, and Tanaka K. 2005. Current role of liver transplantation for the treatment of urea cycle
disorders: a review of the worldwide English literature and 13 cases at Kyoto University. Liver
Transpl 11:1332-1342.
Nagamani SC, Campeau PM, Shchelochkov OA, Premkumar MH, Guse K, Brunetti-Pierri N, Chen Y,
Sun Q, Tang Y, Palmer D, Reddy AK, Li L, Slesnick TC, Feig DI, Caudle S, Harrison D, Salviati L, Marini
JC, Bryan NS, Erez A, and Lee B. 2012a. Nitric-oxide supplementation for treatment of long-term
complications in argininosuccinic aciduria. Am J Hum Genet 90:836-846.
Nagamani SC, Lee B, and Erez A. 2012b. Optimizing therapy for argininosuccinic aciduria. Mol
Genet Metab.
Nassogne MC, Heron B, Touati G, Rabier D, and Saudubray JM. 2005. Urea cycle defects:
management and outcome. J Inherit Metab Dis 28:407-414.
Saudubray J, van den Berghe G, and Walter JH. 2011. Inborn Metabolic Diseases. Wurzburg,
Gemany: Springer.
Scaglia F. 2010. New insights in nutritional management and amino acid supplementation in urea
cycle disorders. Mol Genet Metab 100 Suppl 1:S72-S76.
Thenmozhi AJ, and Subramanian P. 2010. Antioxidant Potential of Momordica charantia in
Ammonium Chloride-induced Hyperammonemic Rats. Evid Based Complement Alternat Med.
Tuchman M, Lee B, Lichter-Konecki U, Summar ML, Yudkoff M, Cederbaum SD, Kerr DS, Diaz GA,
Seashore MR, Lee HS, McCarter RJ, Krischer JP, and Batshaw ML. 2008. Cross-sectional multicenter
study of patients with urea cycle disorders in the United States. Mol Genet Metab 94:397-402.